We are live on ! Find out more
FCMI

Foresite Capital Management I Portfolio holdings

AUM $21.4M
1-Year Est. Return 80.48%
This Fund
S&P 500
This Quarter Est. Return
+15.18%
1 Year Est. Return
-80.48%
3 Year Est. Return
-40.72%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$67.9M
AUM Growth
-$36.5M
Cap. Flow
-$42.3M
Cap. Flow %
-62.36%
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
3
Closed
2

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
AMBI
Ambit Biosciences Corp
AMBI
+$32M
2
TLPH icon
Talphera
TLPH
+$4.48M
3
KPTI icon
Karyopharm Therapeutics
KPTI
+$2.95M
4
XNCR icon
Xencor
XNCR
+$2.6M
5
BDSI
BioDelivery Sciences International, Inc.
BDSI
+$287K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KPTI icon
1
Karyopharm Therapeutics
KPTI
$216M
$37.4M 55.08%
66,618
-5,190
-7% -$2.95M
XNCR icon
2
Xencor
XNCR
$1.3B
$9.35M 13.77%
582,881
-224,475
-28% -$2.6M
BDSI
3
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$8.07M 11.88%
671,092
-18,908
-3% -$287K
OREX
4
DELISTED
Orexigen Therapeutics, Inc.
OREX
$7.48M 11.02%
123,500
– –
RXDX
5
DELISTED
Ignyta, Inc.
RXDX
$3.42M 5.04%
500,000
– –
XLRN
6
DELISTED
Acceleron Pharma
XLRN
$2.17M 3.2%
55,767
– –
TLPH icon
7
Talphera
TLPH
$68.5M
– –
-40,813
Closed -$4.48M
AMBI
8
DELISTED
Ambit Biosciences Corp
AMBI
– –
-2,079,569
Closed -$32M

Similar funds

A
Atlassian San Francisco, California $21M AUM 71.86% 1-Year Est. Return
CVGI
Craft Ventures GP II San Francisco, California $24.1M AUM 83.06% 1-Year Est. Return
AEPI
AH Equity Partners IV Menlo Park, California $24.5M AUM 73.4% 1-Year Est. Return
AGDR
AdamCapital Gestao de Recursos Rio De Janeiro, Brazil $18.1M AUM 32.38% 1-Year Est. Return
N
NanoDimension Woodside, California $24.7M AUM 74.01% 1-Year Est. Return
WL
WiL LLC Palo Alto, California $17.5M AUM 75.04% 1-Year Est. Return
NVPX
Norwest Venture Partners XIII Palo Alto, California $25.8M AUM 76.52% 1-Year Est. Return
SVGI
Sozo Ventures GP I Redwood City, California $16.3M AUM 66.18% 1-Year Est. Return

Foresite Capital Management I's Q4 2014 Portfolio in Review

As of Q4 2014, Foresite Capital Management I held 8 positions worth $67.9M, down 35% from $104M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Foresite Capital Management I withdrew a net $42.3M in Q4 2014, closing 2 positions and reducing 3 holdings. Its most notable exit was Ambit Biosciences Corp, an estimated $32M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 69% a quarter earlier.

  • Foresite Capital Management I's biggest Q4 2014 reduction was Karyopharm Therapeutics, cutting an estimated $2.95M.
  • Foresite Capital Management I fully exited Ambit Biosciences Corp in Q4 2014, selling an estimated $32M.
  • Foresite Capital Management I's ten largest holdings make up 100% of its $67.9M portfolio in Q4 2014.
  • Foresite Capital Management I opened 0 new positions and closed 2 in Q4 2014.
  • Foresite Capital Management I's portfolio value fell 35% quarter-over-quarter to $67.9M.

Based on Foresite Capital Management I's 13F filing for Q4 2014, filed 11 Feb 2015.